Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Its lead candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor being developed for obstructive and non-obstructive HCM. The Senior Director, Biostatistics, is a hands-on program-level statistical leader for BHB-1893, reporting to the VP, Head of Biometrics. The role owns the statistical strategy, design, analysis, and interpretation of late-stage Phase 2 and Phase 3 studies while directly performing substantial statistical work. It manages CRO and vendor biostatistics and programming work, collaborates with external partners, represents biostatistics on program teams and in health authority interactions, and leads statistical contributions to regulatory filings. The role partners with Clinical Development, Clinical Operations, Data Management, Regulatory, Safety, Medical Affairs, and Clinical Pharmacology. It also contributes to the processes and standards of a growing late-stage organization. The ideal candidate has deep late-stage and regulatory expertise, sound scientific judgment, and a preference for hands-on work in a lean, fast-moving biotech environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior